SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-015026
Filing Date
2023-04-27
Accepted
2023-04-27 08:36:57
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A inzy_2023_defa14a.htm DEFA14A 36844
2 GRAPHIC img227424797_0.jpg GRAPHIC 1768128
3 GRAPHIC img227424797_1.jpg GRAPHIC 517450
  Complete submission text file 0000950170-23-015026.txt   3185110
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Filer) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39397 | Film No.: 23852122
SIC: 2834 Pharmaceutical Preparations